Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00019747 · ClinicalTrials.gov registry record · Phase 2
Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
A Phase 2 study, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT00019747 is a Phase 2 study that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 39 participants.
The verdict
NCT00019747, a Phase 2 study, was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
RATIONALE: Thalidomide may stop the growth of colorectal cancer by stopping blood flow to the tumor. Giving thalidomide after surgery may kill any remaining tumor cells. PURPOSE: This randomized phase II trial is studying surgery and thalidomide to see how well they work compared to surgery alone in treating patients with recurrent or metastatic colorectal cancer.
Interventions
- OTHER Placebo
- PROCEDURE adjuvant therapy
- DRUG thalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 1999-08 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00019747
The ClinicalTrials.gov registry entry for NCT00019747 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00019747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00019747 about?
NCT00019747 is a clinical study titled "Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer". RATIONALE: Thalidomide may stop the growth of colorectal cancer by stopping blood flow to the tumor. Giving thalidomide after surgery may kill any remaining tumor cells. PURPOSE: This randomized phase II trial is studying surgery and thalidomide to see how well they work compared to surgery alone i...
What is the current status of trial NCT00019747?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 1999-08. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00019747?
The interventions under investigation include: Placebo (OTHER), adjuvant therapy (PROCEDURE), thalidomide (DRUG).
Who is sponsoring clinical trial NCT00019747?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.